Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Thorac Dis
2022 Oct 01;1410:4081-4095. doi: 10.21037/jtd-22-1261.
Show Gene links
Show Anatomy links
LncRNA KCNQ1OT1 enhances the radioresistance of lung squamous cell carcinoma by targeting the miR-491-5p/TPX2-RNF2 axis.
Liu J
,
Jiang M
,
Guan J
,
Wang Y
,
Yu W
,
Hu Y
,
Zhang X
,
Yang J
.
???displayArticle.abstract???
BACKGROUND: Lung cancer, especially lung squamous cell carcinoma (LUSC), is one of the most common malignant tumors worldwide. Currently, radiosensitization research is a vital direction for the improvement of LUSC therapy. Long non-coding RNAs (lncRNAs) can be novel biomarkers due to their multiple functions in cancers. However, the function and mechanism of lncRNA KCNQ1OT1 in the radioresistance of LUSC remain to be elucidated.
METHODS: The clonogenic assay was employed to determine the radioresistance of SK-MES-1R and NCI-H226R cells. Real-time quantitative polymerase chain reaction (RT-qPCR) and Western blot were conducted for the detection of gene expression. Cell proliferation was determined by the methyl thiazolyl tetrazolium (MTT) assay, colony formation assay, and 5-ethynyl-2'-deoxyuridine (EdU) staining, and cell apoptosis was assessed by flow cytometry. The relationships between genes were also evaluated by applying the luciferase reporter and radioimmunoprecipitation (RIP) assays.
RESULTS: Radioresistant LUSC cells (SK-MES-1R and NCI-H226R) had strong resistance to X-ray irradiation, and lncRNA KCNQ1OT1 was highly expressed in SK-MES-1R and NCI-H226R cells. Moreover, knockdown of lncRNA KCNQ1OT1 prominently suppressed proliferation, attenuated radioresistance, and accelerated the apoptosis of SK-MES-1R and NCI-H226R cells. More importantly, we verified that miR-491-5p was a regulatory target of lncRNA KCNQ1OT1, and Xenopus kinesin-like protein 2 (TPX2) and RING finger protein 2 (RNF2) were the target genes of miR-491-5p. The rescue experiment results also demonstrated that miR-491-5p was involved in the inhibition of cell proliferation and the downregulation of TPX2 and RNF2 expression mediated by lncRNA KCNQ1OT1 knockdown in SK-MES-1R and NCI-H226R cells.
CONCLUSIONS: LncRNA KCNQ1OT1 was associated with the radioresistance of radioresistant LUSC cells, and the lncRNA KCNQ1OT1/miR-491-5p/TPX2-RNF2 axis might be used as a therapeutic target to enhance the radiosensitivity of radioresistant LUSC cells.
Akhurst,
Staging of Non-Small-Cell Lung Cancer.
2018, Pubmed
Akhurst,
Staging of Non-Small-Cell Lung Cancer.
2018,
Pubmed
Alwani,
[MiRNAs - targets in cancer therapy].
2021,
Pubmed
An,
Plk1 interacts with RNF2 and promotes its ubiquitin‑dependent degradation.
2018,
Pubmed
Ashrafizadeh,
Long noncoding RNAs (lncRNAs) in pancreatic cancer progression.
2022,
Pubmed
Castro,
MicroRNAs in lung cancer.
2017,
Pubmed
Chen,
Downregulation of lncRNA NEAT1_2 radiosensitizes hepatocellular carcinoma cells through regulation of miR-101-3p/WEE1 axis.
2019,
Pubmed
Chen,
Long non-coding RNA: An underlying bridge linking neuroinflammation and central nervous system diseases.
2021,
Pubmed
Chen,
miR-491-5p inhibits osteosarcoma cell proliferation by targeting PKM2.
2018,
Pubmed
Correia,
Long Non-Coding RNAs in Cardiovascular Diseases: Potential Function as Biomarkers and Therapeutic Targets of Exercise Training.
2021,
Pubmed
Coudray,
Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning.
2018,
Pubmed
Cui,
Nutrition, microRNAs, and Human Health.
2017,
Pubmed
Dahariya,
Long non-coding RNA: Classification, biogenesis and functions in blood cells.
2019,
Pubmed
Dai,
lncRNA KCNQ1OT1 may function as a competitive endogenous RNA in atrial fibrillation by sponging miR‑223‑3p.
2021,
Pubmed
Fathi,
Emerging roles of miRNAs in the development of pancreatic cancer.
2021,
Pubmed
Florczuk,
miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives.
2017,
Pubmed
Gao,
LncRNA KCNQ1OT1 ameliorates particle-induced osteolysis through inducing macrophage polarization by inhibiting miR-21a-5p.
2018,
Pubmed
Garrido,
Non-centrosomal TPX2-Dependent Regulation of the Aurora A Kinase: Functional Implications for Healthy and Pathological Cell Division.
2016,
Pubmed
Gong,
MicroRNAs-491-5p suppresses cell proliferation and invasion by inhibiting IGF2BP1 in non-small cell lung cancer.
2016,
Pubmed
Gu,
LncRNA KCNQ1OT1 delayed fracture healing through the Wnt/β-catenin pathway.
2019,
Pubmed
Habash,
Clinical and Functional Assays of Radiosensitivity and Radiation-Induced Second Cancer.
2017,
Pubmed
Huang,
LncRNAs in pancreatic cancer.
2016,
Pubmed
Huang,
The novel regulatory role of lncRNA-miRNA-mRNA axis in cardiovascular diseases.
2018,
Pubmed
Huang,
LINC00958-MYC positive feedback loop modulates resistance of head and neck squamous cell carcinoma cells to chemo- and radiotherapy in vitro.
2019,
Pubmed
Jarroux,
History, Discovery, and Classification of lncRNAs.
2017,
Pubmed
Jiang,
Down-regulation of LncRNA TUG1 enhances radiosensitivity in bladder cancer via suppressing HMGB1 expression.
2017,
Pubmed
Kanwal,
MicroRNAs in prostate cancer: Functional role as biomarkers.
2017,
Pubmed
Koike,
TPX2 is a prognostic marker and promotes cell proliferation in neuroblastoma.
2022,
Pubmed
,
Xenbase
Kris,
Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non-Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update.
2017,
Pubmed
Lelli,
Curcumin and Lung Cancer: the Role of microRNAs.
2017,
Pubmed
Li,
Down-regulation of lncRNA KCNQ1OT1 protects against myocardial ischemia/reperfusion injury following acute myocardial infarction.
2017,
Pubmed
Li,
lncRNA KCNQ1OT1 enhances the chemoresistance of oxaliplatin in colon cancer by targeting the miR-34a/ATG4B pathway.
2019,
Pubmed
Li,
Translation of noncoding RNAs: Focus on lncRNAs, pri-miRNAs, and circRNAs.
2017,
Pubmed
Liang,
Long noncoding RNA LINC00958 suppresses apoptosis and radiosensitivity of colorectal cancer through targeting miR-422a.
2021,
Pubmed
Liz,
lncRNAs and microRNAs with a role in cancer development.
2016,
Pubmed
Lu,
miR-491-5p functions as a tumor suppressor by targeting IGF2 in colorectal cancer.
2019,
Pubmed
Luo,
Effects of LncRNA KCNQ1OT1 on proliferation and migration of ovarian cancer cells by Wnt/β-catenin.
2019,
Pubmed
Matsui,
Robustness of Clonogenic Assays as a Biomarker for Cancer Cell Radiosensitivity.
2019,
Pubmed
Mesko,
Proton Therapy in Non-small Cell Lung Cancer.
2018,
Pubmed
Miranda,
Metastasis-directed radiation therapy after radical cystectomy for bladder cancer.
2021,
Pubmed
Mitobe,
Prostate cancer-associated lncRNAs.
2018,
Pubmed
Ning,
Advances and challenges in studying noncoding RNA regulation of drug metabolism and development of RNA therapeutics.
2019,
Pubmed
Nooreldeen,
Current and Future Development in Lung Cancer Diagnosis.
2021,
Pubmed
O'Dowd,
Lung cancer for the non-respiratory physician.
2021,
Pubmed
Paraskevopoulou,
Analyzing MiRNA-LncRNA Interactions.
2016,
Pubmed
Skřičková,
[Non-small cell lung cancer].
2018,
Pubmed
Sun,
miR-491-5p, mediated by Foxi1, functions as a tumor suppressor by targeting Wnt3a/β-catenin signaling in the development of gastric cancer.
2017,
Pubmed
Sun,
The role of lncRNA MSC-AS1/miR-29b-3p axis-mediated CDK14 modulation in pancreatic cancer proliferation and Gemcitabine-induced apoptosis.
2019,
Pubmed
Tang,
LncRNA KCNQ1OT1 activated by c-Myc promotes cell proliferation via interacting with FUS to stabilize MAP3K1 in acute promyelocytic leukemia.
2021,
Pubmed
Timmerman,
Long-term Results of Stereotactic Body Radiation Therapy in Medically Inoperable Stage I Non-Small Cell Lung Cancer.
2018,
Pubmed
Tomii,
TPX2 expression is associated with poor survival in gastric cancer.
2017,
Pubmed
,
Xenbase
Wang,
KCNQ1OT1 aggravates cell proliferation and migration in bladder cancer through modulating miR-145-5p/PCBP2 axis.
2019,
Pubmed
Wang,
STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4.
2017,
Pubmed
Wang,
Retraction Note to: LncRNA SNHG12 regulates the radiosensitivity of cervical cancer through the miR-148a/CDK1 pathway.
2022,
Pubmed
Wei,
Knockdown of RNF2 induces cell cycle arrest and apoptosis in prostate cancer cells through the upregulation of TXNIP.
2017,
Pubmed
Winkle,
Noncoding RNA therapeutics - challenges and potential solutions.
2021,
Pubmed
Wu,
Knockdown of Lncrna PVT1 Enhances Radiosensitivity in Non-Small Cell Lung Cancer by Sponging Mir-195.
2017,
Pubmed
Wu,
LncRNAs: From Basic Research to Medical Application.
2017,
Pubmed
Xian,
LncRNA KCNQ1OT1 enhanced the methotrexate resistance of colorectal cancer cells by regulating miR-760/PPP1R1B via the cAMP signalling pathway.
2019,
Pubmed
Xu,
LncRNA KCNQ1OT1 promotes Atg12-mediated autophagy via inhibiting miR-26a-5p in ischemia reperfusion.
2021,
Pubmed
Xu,
MiR-491-5p negatively regulates cell proliferation and motility by targeting PDGFRA in prostate cancer.
2017,
Pubmed
Xue,
MicroRNAs, Long Noncoding RNAs, and Their Functions in Human Disease.
2017,
Pubmed
Xue,
Long non-coding RNA LINC00680 functions as a ceRNA to promote esophageal squamous cell carcinoma progression through the miR-423-5p/PAK6 axis.
2022,
Pubmed
Yang,
Knockdown of RNF2 enhances the radiosensitivity of squamous cell carcinoma in lung.
2019,
Pubmed
Yang,
Long noncoding RNA LINC00483/microRNA-144 regulates radiosensitivity and epithelial-mesenchymal transition in lung adenocarcinoma by interacting with HOXA10.
2019,
Pubmed
Yi,
Long noncoding RNA PTPRG-AS1 acts as a microRNA-194-3p sponge to regulate radiosensitivity and metastasis of nasopharyngeal carcinoma cells via PRC1.
2019,
Pubmed
Yu,
LncRNA GAS5 enhances radiosensitivity of hepatocellular carcinoma and restricts tumor growth and metastasis by miR-144-5p/ATF2.
2021,
Pubmed
Zhang,
miR-491-5p suppresses cell growth and invasion by targeting Notch3 in nasopharyngeal carcinoma.
2016,
Pubmed
Zhang,
LncRNA KCNQ1OT1 regulates proliferation and cisplatin resistance in tongue cancer via miR-211-5p mediated Ezrin/Fak/Src signaling.
2018,
Pubmed
Zhang,
Rnf2 knockdown reduces cell viability and promotes cell cycle arrest in gastric cancer cells.
2017,
Pubmed
Zhao,
LncRNA KCNQ1OT1 promotes the development of diabetic nephropathy by regulating miR-93-5p/ROCK2 axis.
2021,
Pubmed
Zhao,
Long non-coding RNA KCNQ1OT1 increases the expression of PDCD4 by targeting miR-181a-5p, contributing to cardiomyocyte apoptosis in diabetic cardiomyopathy.
2021,
Pubmed
Zhao,
Identification of lncRNA-miRNA-mRNA regulatory network associated with epithelial ovarian cancer cisplatin-resistant.
2019,
Pubmed
Zheng,
LncRNA KCNQ1OT1 is overexpressed in non-small cell lung cancer and its expression level is related to clinicopathology.
2019,
Pubmed
Zhou,
LINC02532 Contributes to Radiosensitivity in Clear Cell Renal Cell Carcinoma through the miR-654-5p/YY1 Axis.
2021,
Pubmed
Zou,
Overexpression of TPX2 is associated with progression and prognosis of prostate cancer.
2018,
Pubmed
,
Xenbase
